Dr. COVELIERS · Checked.be

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Dr. COVELIERS is 0.2% (very low). The 2025 annual accounts show equity of €3k and a net result of €66k. Equity is growing by ~47.4% per year across the filed fiscal years. Its solvency ranks better than 15% of 2209 sector peers (fiscal year 2025). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 5 annual accounts.

Signals

2 signals · with evidence

Weak solvency vs sector

Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 2209 sector peers (2025).

View the sector comparison

Consistently profitable

Positive net result in the two most recent financial years (2024 and 2025).

View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-03-2026, 127 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

How we compute the deadline

The year end is derived from 5 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	26-03-2026	127 d early	2026-00062549
31-12-2024	31-07-2025	04-07-2025	27 d early	2025-00228804
31-12-2023	31-07-2024	26-06-2024	35 d early	2024-00164284
31-12-2022	31-07-2023	30-08-2023	30 d late	2023-00377242
31-12-2021	31-07-2022	29-08-2022	29 d late	2022-20332956

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

More than 3 years active

Founded in 2020, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

0.2% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Young company +Higher-failure-rate region +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€66k-30.7%

Working capital€-2k

CSV export

Annual accounts & ratios

Source: NBB · 2025

Annual accounts filed on 26-03-2026 with the NBB · fiscal year 2025 · micro

Operating resultNet result

Trajectory (indicative)

Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.

growing Equity: growth of ~47.4%/year over 5 fiscal years, indicative, assuming unchanged policy.

Solid line = filed figures · dashed = extended trend · area = indicative range.

How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison

Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	3.2%	58.2%	better than 15% of 2209 sector peers
Net result	€66k	€60k	better than 53% of 2207 sector peers
Equity	€3k	€74k	better than 10% of 2209 sector peers
Gross operating margin	€90k	€96k	better than 48% of 2209 sector peers
Total assets	€77k	€187k	better than 19% of 2209 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

Sector position over time

Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).

Solvency P15

Improving position over 2021-2025 · n=1833-6573

Net result P53

Weakening position over 2021-2025 · n=1833-6567

Equity P10

Improving position over 2021-2025 · n=1833-6573

Gross operating margin P48

Weakening position over 2021-2025 · n=1834-6575

Describes the position versus peers, not a forecast.

EBITDA

€89k

-30.2% 21-25

Net profit

€66k

-30.7% 21-25

Cash flow

€71k

-29.4% 21-25

Total assets

€77k

-76.8% 21-25

Equity

€3k

-99.2% 21-25

Working capital

€-2k

- 21-25

Income taxes

€18k

-33.4% 21-25

Dividends

€391k

- 21-25

Debt

€75k

+1000.3% 21-25

Debt ≤ 1y

€75k

+1000.3% 21-25

Current ratio

0.98

-98.0% 21-25

Quick ratio

0.98

-98.0% 21-25

Solvency

3.2%

-96.7% 21-25

Debt / equity

29.94

+143691.3% 21-25

ROE

2659.2%

+8954.6% 21-25

ROA

85.9%

+198.8% 21-25

Interest coverage

596.48

+14.3% 21-25

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2025
Deposit	micro
Revenue	-
EBITDA	€89k
Net profit	€66k
Cash flow	€71k
Staff costs	-
Income taxes	€18k
Dividends	€391k
Total assets	€77k
Equity	€3k
Debt	€75k
of which ≤ 1y	€75k
of which > 1y	-
Working capital	€-2k
Employees (FTE)	-

Ratios (computed)

	2025
Current ratio	0.98
Quick ratio	0.98
Working capital ratio	-2.3%
Solvency	3.2%
Debt / equity	29.94
Long-term debt ratio	-
Interest coverage	596.48
Gross margin	-
Net margin	-
ROA	85.9%
ROE	2659.2%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2025

Assets

Fixed assets €4k · 5.5% Current assets €73k · 94.5%

Equity & liabilities

Equity €3k · 3.2% Debt €75k · 96.8%

Full annual accounts

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€77k
Fixed assets	21/28	€4k
Tangible fixed assets	22/27	€4k
Current assets	29/58	€73k
Amounts receivable within one year	40/41	€19k
Investments	50/53	€44k
Cash & bank	54/58	€7k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€77k
Equity	10/15	€3k
Contributions / capital	10/11	€3k
Amounts payable	17/49	€75k
Amounts payable within one year	42/48	€75k
Trade debts payable within one year	44	€4k
Income statement
Gross operating margin	9900	€90k
Operating result	9901	€85k
Financial income	75	€0
Financial charges	65	€150
Result before taxes	9903	€84k
Income taxes	67/77	€18k
Net result for the period	9904	€66k
Result to be appropriated	9905	€66k

You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan. See plans →

Ratios computed by Checked.

Health barometer

FY 2025 · computed

45 / 100 Fair

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register

exact location from the address register On OpenStreetMap

2 companies at this address See who is registered here

Establishment units

1 location

Dr. COVELIERS

Rue des Eglantiers 7, 4053 ChaudfontaineActiviteiten van huisartspraktijken

since 20202.308.714.519

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels1

Ground area1,073 m²

Buildings1

Building footprint233 m²

Volume (LiDAR)1,067 m³

Tallest building6.0 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
62030C0251/00W000	Wallonia	1,073 m²	1 · 233 m²	6.0 m · 2 fl.

Methodology

via registered seat: 1

1 of 1 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

2 acts

Address history · 1

03-06-2026

Seat change: new: Rue des églantiers 7 à 4053 EMBOURG (Région wallonne), old: Avenue du Centenaire 61 à 4053 Chaudfontaine, date: 2025-09-01

All acts · 2 updated 2 months ago

2026

03-06-2026 Seat change · Board meeting · Officer appointment · Act object Open-capture extraction

Filing: 2026-05-26 · Dr COVELIERS
Publication: 2026-06-03 · Dr COVELIERS
Seat change: new: Rue des églantiers 7 à 4053 EMBOURG (Région wallonne), old: Avenue du Centenaire 61 à 4053 Chaudfontaine, date: 2025-09-01 · Dr COVELIERS
Board meeting: date: 2025-09-01, location: Chaudfontaine, Avenue du Centenaire 61 · Dr COVELIERS
Officer appointment: role: administrateur · Amaury COVELIERS
Act object: TRANSFERT DU SIEGE SOCIAL

Summary: Seat change · Board meeting · Officer appointment · Act object

Original publication ↗

2020

07-10-2020 Incorporation of a new SRL Incorporation

Summary: oprichting

Original publication ↗

Analysis

Snowflake analysis

financial profile on 5 axes

57 / 100

Mixed profile: strong on profitability, weaker on solvency.

All 5 axes are computed from data Checked has read.

Health 45

Profitability 100

Solvency 13

Growth 32

Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers

Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon

The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works